PGNY - Progyny, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
New York,
United States
Type: Equity
PGNY price evolution
PGNY
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $94.96 | $114.96 | $97.3 | |
| Short term investments | $167.23 | $256.87 | $273.79 | |
| Net receivables | $280.72 | $293.8 | $297.21 | $241.87 |
| Inventory | ||||
| Total current assets | $546.3 | $582.24 | $681.51 | $640.41 |
| Long term investments | ||||
| Property, plant & equipment | $29.37 | $28.44 | $27.41 | $27.82 |
| Goodwill & intangible assets | $17.09 | $11.88 | $11.88 | |
| Total noncurrent assets | $116.39 | $112.79 | $116.21 | |
| Total investments | $167.23 | $256.87 | $273.79 | |
| Total assets | $659.97 | $698.63 | $794.3 | $756.62 |
| Current liabilities | ||||
| Accounts payable | $130.46 | $151.75 | $130.17 | $125.43 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $208.47 | $225.38 | $205.92 | $185.95 |
| Long term debt | $17.06 | $16.78 | $17.24 | |
| Total noncurrent liabilities | $17.06 | $16.78 | $17.24 | |
| Total debt | $17.06 | $16.78 | $17.24 | |
| Total liabilities | $225.1 | $242.44 | $222.7 | $203.19 |
| Shareholders' equity | ||||
| Retained earnings | $133.78 | $123.35 | $106.87 | $89.97 |
| Other shareholder equity | $0.23 | $2.02 | $2.75 | $2.82 |
| Total shareholder equity | $456.19 | $571.6 | $553.43 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $97.3 | $120.08 | $91.41 | $70.31 |
| Short term investments | $273.79 | $69.22 | $28 | $38.99 |
| Net receivables | $241.87 | $240.07 | $134.56 | $75.66 |
| Inventory | ||||
| Total current assets | $640.41 | $433.86 | $258.54 | $190.22 |
| Long term investments | ||||
| Property, plant & equipment | $27.82 | $15.27 | $12.83 | $12.07 |
| Goodwill & intangible assets | $11.88 | $11.98 | $12.48 | $13.09 |
| Total noncurrent assets | $116.21 | $109.13 | $99.53 | $63.7 |
| Total investments | $273.79 | $69.22 | $28 | $38.99 |
| Total assets | $756.62 | $542.99 | $358.06 | $253.93 |
| Current liabilities | ||||
| Accounts payable | $125.43 | $109.29 | $61.4 | $43.51 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $185.95 | $159.54 | $98.82 | $77.79 |
| Long term debt | $17.24 | $6.48 | $7.42 | $8.32 |
| Total noncurrent liabilities | $17.24 | $6.48 | $7.42 | $9.19 |
| Total debt | $17.24 | $6.48 | $7.42 | $8.32 |
| Total liabilities | $203.19 | $166.02 | $106.24 | $86.98 |
| Shareholders' equity | ||||
| Retained earnings | $89.97 | $27.93 | -$2.42 | -$68.19 |
| Other shareholder equity | $2.82 | $0.5 | -$0.09 | $0 |
| Total shareholder equity | $553.43 | $376.97 | $251.82 | $166.95 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $286.63 | $304.09 | $278.08 | $269.94 |
| Cost of revenue | $235.81 | $215.67 | $213.05 | |
| Gross Profit | $59.24 | $68.28 | $62.41 | $56.89 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $47.59 | $43.88 | $43.09 | |
| Total operating expenses | $46.79 | $47.59 | $43.88 | $43.09 |
| Operating income | $20.69 | $18.52 | $13.8 | |
| Income from continuing operations | ||||
| EBIT | $24.25 | $21.88 | $15.52 | |
| Income tax expense | $7.54 | $8.58 | $5.62 | $2.79 |
| Interest expense | $5.5 | -$0.82 | -$0.63 | -$0.74 |
| Net income | ||||
| Net income | $10.42 | $16.48 | $16.9 | $13.47 |
| Income (for common shares) | $16.48 | $16.9 | $13.47 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1088.6 | $786.91 | $500.62 | $344.86 |
| Cost of revenue | $849.8 | $619.59 | $388.49 | $274.8 |
| Gross Profit | $238.8 | $167.32 | $112.14 | $70.06 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $176.62 | $143.98 | $79.8 | $61.71 |
| Total operating expenses | $176.62 | $143.98 | $79.8 | $61.71 |
| Operating income | $62.18 | $23.34 | $32.34 | $8.35 |
| Income from continuing operations | ||||
| EBIT | $67.39 | $23.63 | $31.97 | $8.56 |
| Income tax expense | $8.65 | -$5.92 | -$33.33 | -$37.78 |
| Interest expense | -$3.3 | -$0.81 | -$0.46 | -$0.12 |
| Net income | ||||
| Net income | $62.04 | $30.36 | $65.77 | $46.46 |
| Income (for common shares) | $62.04 | $30.36 | $65.77 | $46.46 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $16.48 | $16.9 | $13.47 | |
| Operating activities | ||||
| Depreciation | $0.75 | $0.72 | $0.63 | |
| Business acquisitions & disposals | -$5.3 | |||
| Stock-based compensation | $33.04 | $31.05 | $28.8 | |
| Total cash flows from operations | $56.69 | $25.73 | $37.66 | |
| Investing activities | ||||
| Capital expenditures | -$0.87 | -$0.85 | -$0.68 | |
| Investments | $92.27 | $20.19 | -$92.73 | |
| Total cash flows from investing | $120.8 | $86.1 | $19.34 | -$93.41 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$159.58 | -$22.45 | $1.67 | |
| Net borrowings | ||||
| Total cash flows from financing | -$253.55 | -$162.79 | -$27.41 | -$5.03 |
| Effect of exchange rate | -$0.01 | -$0 | $0 | |
| Change in cash and equivalents | -$5.82 | -$20 | $17.66 | -$60.78 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $62.04 | $30.36 | $65.77 | $46.46 |
| Operating activities | ||||
| Depreciation | $2.28 | $1.6 | $1.3 | $1.91 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $122.61 | $100.75 | $33.71 | $12.82 |
| Total cash flows from operations | $188.81 | $80.39 | $26.04 | $36.2 |
| Investing activities | ||||
| Capital expenditures | -$3.64 | -$3.24 | -$2.13 | -$1.04 |
| Investments | -$196.88 | -$40.63 | $10.89 | -$38.99 |
| Total cash flows from investing | -$200.53 | -$43.87 | $8.77 | -$40.03 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $6.13 | $4.22 | $4.27 | $2.68 |
| Net borrowings | ||||
| Total cash flows from financing | -$11.07 | -$7.86 | -$13.7 | -$6.25 |
| Effect of exchange rate | $0 | |||
| Change in cash and equivalents | -$22.78 | $28.66 | $21.11 | -$10.08 |
News
Fundamentals
| Market cap | $1.39B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 88.34M |
| Revenue | $1.14B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $57.27M |
| Revenue Q/Q | 2.04% |
| Revenue Y/Y | 10.24% |
| P/E ratio | 24.29 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.22 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $0.65 |
|---|---|
| ROA | 7.87% |
| ROE | N/A |
| Debt/Equity | 0.37 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.62 |
| Quick ratio | N/A |